The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Pyridine-2-carboxylic acid [4-((1R,7S)-3,5-dioxo-4-aza-tricyclo[5.2.1.0(2,6)]dec-8-en-4-yl)-phenyl]amide ID: ALA4757473
PubChem CID: 162656571
Max Phase: Preclinical
Molecular Formula: C21H17N3O3
Molecular Weight: 359.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc(N2C(=O)C3C(C2=O)[C@H]2C=C[C@@H]3C2)cc1)c1ccccn1
Standard InChI: InChI=1S/C21H17N3O3/c25-19(16-3-1-2-10-22-16)23-14-6-8-15(9-7-14)24-20(26)17-12-4-5-13(11-12)18(17)21(24)27/h1-10,12-13,17-18H,11H2,(H,23,25)/t12-,13+,17?,18?
Standard InChI Key: CXQVAVZDFUGKNI-NLKGSNSHSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
7.5442 -4.9148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9488 -4.2070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5382 -3.5048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7232 -3.5092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3206 -4.2217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7335 -4.9209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7660 -4.2030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1711 -3.4933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9883 -3.4893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7591 -2.7876 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3973 -4.1960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2137 -4.1923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6196 -3.4820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2032 -2.7740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3881 -2.7812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5034 -4.2294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0162 -3.5702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0287 -4.8923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2492 -4.6473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2399 -3.8256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5276 -3.4251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8200 -3.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8293 -4.6634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5462 -5.0684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2641 -2.7916 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2877 -5.6674 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7351 -4.2098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5205 -2.6043 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
3.5412 -5.8854 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 9 1 0
5 16 1 0
16 17 1 0
17 20 1 0
19 18 1 0
18 16 1 0
19 20 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
17 25 2 0
18 26 2 0
21 27 1 0
24 27 1 0
21 28 1 1
24 29 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.39Molecular Weight (Monoisotopic): 359.1270AlogP: 2.65#Rotatable Bonds: 3Polar Surface Area: 79.37Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 0.49CX LogP: 1.96CX LogD: 1.96Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.67Np Likeness Score: -1.40
References 1. Davis DC,Bungard JD,Chang S,Rodriguez AL,Blobaum AL,Boutaud O,Melancon BJ,Niswender CM,Jeffrey Conn P,Lindsley CW. (2021) Lead optimization of the VU0486321 series of mGlu PAMs. Part 4: SAR reveals positive cooperativity across multiple mGlu receptor subtypes leading to subtype unselective PAMs., 32 [PMID:33253881 ] [10.1016/j.bmcl.2020.127724 ]